Bladder cancer is the fourth leading cause of cancer in men. Improvements in cancer care have led to patients living longer. Five-year relative survival rates in patients with localized and regional bladder cancer have been reported to be 69 and 34%, respectively.

Depending on Tumor characteristics, many patients require radical cystectomy with lymph node dissection and urinary diversion. For diversion, various techniques including ileal conduit, orthotopic neobladder (ONB) and continent cutaneous urinary diversion (CCUD) may be utilized based on patient characteristics and surgeon preferences.